Ownership history in CITIGROUP INC · 35 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 17,118 | -29,418 | -63.2% | 0.00% | $813K | — |
| 2025 Q2 | ADDED | 46,536 | +19,536 | +72.4% | 0.00% | $2.5M | — |
| 2025 Q2 | UNCHANGED | 27,000 | — | 0% | 0.00% | $1.4M | — |
| 2025 Q2 | REDUCED | 27,000 | -207,172 | -88.5% | 0.00% | $1.4M | — |